Stockscreener 앱 받기
9.50
2.48%
0.23
시간 외 거래:
9.50
전일 마감가:
$9.27
열려 있는:
$9.28
하루 거래량:
1.16M
Relative Volume:
1.13
시가총액:
$924.75M
수익:
$1.85M
순이익/손실:
$-95.19M
주가수익비율:
-4.2777
EPS:
-2.2208
순현금흐름:
$-86.88M
1주 성능:
+0.00%
1개월 성능:
+31.22%
6개월 성능:
+100.42%
1년 성능:
+153.33%
1일 변동 폭
$9.27
$9.90
1주일 범위
$9.05
$9.90
52주 변동 폭
$2.85
$10.14
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
9.50 | 916.96M | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-12 | 재개 | Cantor Fitzgerald | Overweight |
| 2026-03-11 | 개시 | Wells Fargo | Overweight |
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
모두보기
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp. Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Pivotal Trial - marketscreener.com
Anteris Technologies Global Receives French Regulator's Approval for DurAVR Trial in Aortic Stenosis - marketscreener.com
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance - The Manila Times
Why Is Anteris Technologies (ASX: AVR) Trading Near a 52-Week High? - Kalkine
Insider Scoop: Major Director Buy Signals Fresh Confidence in Anteris Technologies Global Corp. - TipRanks
Anteris Director Susan Knight Buys First Stake in Company - TipRanks
Anteris Investors Shift From ASX CDIs to Nasdaq Common Stock in May - TipRanks
Anteris Technologies (AVR) director purchases 11,000 shares in open market - Stock Titan
Why Is Anteris Technologies Global Corp. (AVR) Stock Up Today? - Meyka
Anteris Options Lapse, Trimming Potential Future Dilution - TipRanks
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR) - The Globe and Mail
Anteris (NASDAQ: AVR) signs $250M at-the-market sales agreement with TD Cowen - Stock Titan
ChartWatch ASX scans: Brazilian Rare Earths, Echoiq, Weebit Nano, Anteris Technologies, Global X Semiconductor ETF - MSN
AVR - Finviz
Anteris Technologies Global Corp. Q1 2026 Earnings: EPS Misses Expectations as Stock RisesWeak Earnings Momentum - The Legal Advocate
Anteris launches $250m at-the-market program to fund structural heart push - TipRanks
Anteris Technologies Global Corp plans to issue up to $250 million in common stock through TD Cowen as the underwriter. - Bitget
Anteris Technologies Global Launches $250 Million ATM Offering Under Sales Agreement With TD Cowen - TradingView
Anteris (NASDAQ: AVR) launches $250M at-the-market share program - Stock Titan
Anteris Technologies (NASDAQ: AVR) establishes $250M ATM with TD Cowen - Stock Titan
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Pre-Revenue Biotech Posts Wider-Than-Expected Loss, Stock Rallies on Pipeline OptimismCash Flow Report - newsline.com
ChartWatch ASX Scans: Brazilian Rare Earths, Echoiq, Weebit Nano. Anteris Technologies, Global X Semiconductor ETF - Market Index
Anteris Technologies Global : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
Director Susan Knight reports initial insider status at Anteris (NASDAQ: AVR) - Stock Titan
Number of shareholders of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Stephen Denaro details indirect Anteris (AVR) share and option holdings - Stock Titan
Nantahala holds 6,143,154 shares of Anteris (AVR) as of 03/31/2026 - Stock Titan
AVR Maintained by Barclays -- Price Target Raised to $18.00 - GuruFocus
We Think Anteris Technologies Global (ASX:AVR) Can Afford To Drive Business Growth - simplywall.st
Anteris Technologies Global Corp. (AVR) Gets a Buy from TD Cowen - The Globe and Mail
Anteris Announces Results for the First Quarter of 2026 - Sahm
Anteris Technologies Adds Experienced Financial Leaders to Board - The Globe and Mail
TradingKey - TradingKey
Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn Situation - Yahoo Finance
How Should Investors Value Anteris Technologies Global Corp (AVR - GuruFocus
Anteris Technologies appoints two directors to board - Investing.com
Anteris Technologies appoints two directors to board By Investing.com - Investing.com South Africa
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors - The Manila Times
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anteris Technologies Global Corp 주식 (AVR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
5.23%
자본화:
|
볼륨(24시간):